Clinical Trials List
Protocol NumberFAPI_2022/07/06 V3
2022-01-01 - 2024-12-31
Phase II
Recruiting1
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2023/03/10
Investigators and Locations
Co-Principal Investigator
- Cheng-Ta Yang Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- 吳青陽 Division of Thoracic Surgery
- Tzu-Pei Su Division of Nuclear Medicine
- 枋岳甫 Division of Infectious Disease
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
103 participants
-
Global
0 participants
